Cargando…
Distinct epilepsy phenotypes and response to drugs in KCNA1 gain‐ and loss‐of function variants
A wide phenotypic spectrum of neurological diseases is associated with KCNA1 (Kv1.1) variants. To investigate the molecular basis of such a heterogeneous clinical presentation and identify the possible correlation with in vitro phenotypes, we compared the functional consequences of three heterozygou...
Autores principales: | Miceli, Francesco, Guerrini, Renzo, Nappi, Mario, Soldovieri, Maria Virginia, Cellini, Elena, Gurnett, Christina A., Parmeggiani, Lucio, Mei, Davide, Taglialatela, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299230/ https://www.ncbi.nlm.nih.gov/pubmed/34778950 http://dx.doi.org/10.1111/epi.17118 |
Ejemplares similares
-
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine
por: Barrese, Vincenzo, et al.
Publicado: (2010) -
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy
por: Syrbe, Steffen, et al.
Publicado: (2015) -
The Voltage-Sensing Domain of K(v)7.2 Channels as a Molecular Target for Epilepsy-Causing Mutations and Anticonvulsants
por: Miceli, Francesco, et al.
Publicado: (2011) -
A novel homozygous KCNQ3 loss‐of‐function variant causes non‐syndromic intellectual disability and neonatal‐onset pharmacodependent epilepsy
por: Lauritano, Anna, et al.
Publicado: (2019) -
KCNA1 gain‐of‐function epileptic encephalopathy treated with 4‐aminopyridine
por: Müller, Peter, et al.
Publicado: (2023)